House Oversight Committee Chair James Comer (R-KY) (Tom Williams/CQ Roll Call via AP Images)

House to mark up bill tar­get­ing Chi­nese biotech and ge­nomics com­pa­nies

The House Over­sight Com­mit­tee will mark up a far-reach­ing bill on May 15 that, if passed, could force many US bio­phar­ma com­pa­nies to cut ties with WuXi and sev­er­al oth­er Chi­nese life sci­ences con­trac­tors, a con­gres­sion­al aide con­firmed to End­points News.

The markup sig­nals build­ing, bi­par­ti­san mo­men­tum on the close­ly-watched bill that could have wide-rang­ing im­pli­ca­tions for dozens of com­pa­nies. A sim­i­lar bill passed out of the Home­land Se­cu­ri­ty and Gov­ern­men­tal Af­fairs Com­mit­tee ear­li­er this spring.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.